(RTTNews) - AstraZeneca (AZN.L, AZN) announced Imfinzi was recommended for approval in the European Union by CHMP as first and only immunotherapy for limited-stage small cell lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback